Stocks & Investing
Fri, April 5, 2024
[ Fri, Apr 05th 2024
] - WOPRAI
Fri, March 22, 2024
[ Fri, Mar 22nd 2024
] - WOPRAI
Wed, November 15, 2023
[ Wed, Nov 15th 2023
] - WOPRAI
Tue, October 24, 2023
[ Tue, Oct 24th 2023
] - WOPRAI
Fri, March 10, 2023
[ Fri, Mar 10th 2023
] - WOPRAI
Tue, January 24, 2023
[ Tue, Jan 24th 2023
] - WOPRAI
Fri, December 30, 2022
[ Fri, Dec 30th 2022
] - WOPRAI
Tue, December 20, 2022
[ Tue, Dec 20th 2022
] - WOPRAI
Wed, December 1, 2021
[ Wed, Dec 01st 2021
] - WOPRAI
Mon, March 1, 2021
[ Mon, Mar 01st 2021
] - WOPRAI
Mon, February 3, 2020
[ Mon, Feb 03rd 2020
] - WOPRAI
Tue, November 19, 2019
[ Tue, Nov 19th 2019
] - WOPRAI
Joshua Schimmer Reiterated (CABA) at Buy and Held Target at $50 on, Apr 5th, 2024
Joshua Schimmer of Cantor Fitzgerald, Reiterated "Cabaletta Bio, Inc." (CABA) at Buy and Held Target at $50 on, Apr 5th, 2024.
Joshua has made no other calls on CABA in the last 4 months.
There are 4 other peers that have a rating on CABA. Out of the 4 peers that are also analyzing CABA, 0 agree with Joshua's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Joshua
- Samantha Semenkow of "Citigroup" Maintained at Strong Buy with Increased Target to $30 on, Thursday, April 4th, 2024
- Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $35 on, Friday, March 22nd, 2024
- Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $30 on, Friday, March 22nd, 2024
- Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $36 on, Monday, February 5th, 2024
